Clinical and experimental dermatology

Using light-based treatment for a rare scalp inflammation causing hair loss

Updated

Abstract

A 26-year-old man experienced significant improvement in folliculitis decalvans after 25 months of systemic photodynamic therapy.

  • Folliculitis decalvans is estimated to account for approximately 10% of primary cicatricial alopecia cases.
  • Dysfunctional immune activity and Staphylococcus aureus are potentially key factors in the condition.
  • Systemic photodynamic therapy using ultraviolet light and porfimer sodium showed promising results as a monotherapy.
  • This treatment is associated with strong antibacterial effects and minimal resistance.
  • Systemic photodynamic therapy may also enhance local immune response and improve scar healing.
  • Significant adverse effects from this therapy are rare when appropriate aftercare is provided.

Simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free